88 related articles for article (PubMed ID: 2513950)
21. Pre-sepsis prophylaxis and empirical treatment of febrile patients with neutropenia in acute leukaemia.
Advani SH; Ahuja HG; Pai MR; Saikia T; Gopal R; Nair CN
J Assoc Physicians India; 1986 Aug; 34(8):559-62. PubMed ID: 3466893
[No Abstract] [Full Text] [Related]
22. A prospective randomized trial of central venous catheter removal versus intravenous amphotericin B in febrile neutropenic patients.
Lazarus HM; Lowder JN; Anderson JM; Herzig RH
JPEN J Parenter Enteral Nutr; 1984; 8(5):501-5. PubMed ID: 6541714
[TBL] [Abstract][Full Text] [Related]
23. Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
Wingard JR; Leather HL; Wood CA; Gerth WC; Lupinacci RJ; Berger ML; Mansley EC
Am J Health Syst Pharm; 2007 Mar; 64(6):637-43. PubMed ID: 17353573
[TBL] [Abstract][Full Text] [Related]
24. Decisions about voriconazole versus liposomal amphotericin B.
Walsh TJ; Lee J; Dismukes WE
N Engl J Med; 2002 May; 346(19):1499; author reply 1499. PubMed ID: 12000825
[No Abstract] [Full Text] [Related]
25. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
Noel GJ
J Pediatr; 1999 Sep; 135(3):399. PubMed ID: 10523149
[No Abstract] [Full Text] [Related]
26. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial therapy--special considerations in neutropenic patients.
Rodriguez V; Bodey GP
Clin Haematol; 1976 Jun; 5(2):347-60. PubMed ID: 181192
[No Abstract] [Full Text] [Related]
28. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
Cagnoni PJ; Walsh TJ; Prendergast MM; Bodensteiner D; Hiemenz S; Greenberg RN; Arndt CA; Schuster M; Seibel N; Yeldandi V; Tong KB
J Clin Oncol; 2000 Jun; 18(12):2476-83. PubMed ID: 10856108
[TBL] [Abstract][Full Text] [Related]
29. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of empirical antibiotic therapy in febrile neutropenic patients.
Barnes RA; Rogers TR
Br J Haematol; 1987 May; 66(1):137-40. PubMed ID: 3593650
[TBL] [Abstract][Full Text] [Related]
31. Fungal infection and fever of unknown origin in neutropenic patients.
Bodey GP
Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
[No Abstract] [Full Text] [Related]
32. Empirical antifungal therapy for persistent fever in patients with neutropenia.
Chandrasekar PH
Clin Infect Dis; 2001 Jan; 32(2):320-1. PubMed ID: 11170928
[No Abstract] [Full Text] [Related]
33. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
[TBL] [Abstract][Full Text] [Related]
34. Liposomal amphotericin B for fever and neutropenia.
Winston DJ; Schiller GJ; Territo MC
N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
[No Abstract] [Full Text] [Related]
35. Liposomal amphotericin B for fever and neutropenia.
Rakita R
N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
[No Abstract] [Full Text] [Related]
36. A randomized trial of oral vancomycin in neutropenic patients.
Guyotat D; Plonton C; Fiere D
Prog Clin Biol Res; 1985; 181():263-5. PubMed ID: 3895236
[No Abstract] [Full Text] [Related]
37. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
38. Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
Collins CD; Stuntebeck ER; DePestel DD; Stevenson JG
Clin Drug Investig; 2007; 27(4):233-41. PubMed ID: 17358095
[TBL] [Abstract][Full Text] [Related]
39. Caspofungin versus liposomal amphotericin B: are they really comparable?
Sekine L; Humbwavali J; Wolff FH; Barcellos NT
Pediatr Infect Dis J; 2010 Oct; 29(10):985-6; author reply 986-7. PubMed ID: 20859182
[No Abstract] [Full Text] [Related]
40. Septicemia during antibiotic therapy in neutropenic patients.
Balducci L; Newcomb MM; Morrison FS
South Med J; 1979 Jul; 72(7):889-90. PubMed ID: 451708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]